David Vermijlen

Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer

Francesco Dieli, David Vermijlen, Fabio Fulfaro et al. · Cancer Research · 2007 · 476 citations · Full text

Microbial exposure during early human development primes fetal immune cells

Archita Mishra, Ghee Chuan Lai, Jing Yao Leong et al. · Cell · 2021 · 303 citations · Full text

<i>In vivo</i> manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

Serena Meraviglia, Matthias Eberl, David Vermijlen et al. · Clinical & Experimental Immunology · 2010 · 288 citations · Full text

Human cytomegalovirus elicits fetal γδ T cell responses in utero

David Vermijlen, Margreet Brouwer, Catherine Donner et al. · The Journal of Experimental Medicine · 2010 · 211 citations · Full text

Maternal Immunization, Unconventional T Cells, Adaptive Immune System +12

Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire

Tanya Dimova, Margreet Brouwer, Françoise Gosselin et al. · Proceedings of the National Academy of Sciences · 2015 · 209 citations · Full text